pandemic, epidemic or outbreak of an infectious disease, including COVID-19, adversely affects our business, financial condition and results of operations, it may also have the effect of heightening …
Consumer direct pricing is an affordability solution under our pharma direct offering that allows pharma manufacturers to use our platform to set and fund a portion of the consumer cash price for the…
s aggregate demand to negotiate prescription medication prices with pharmacies and pharma manufacturers. PBMs find most of their demand through relationships with insurance companies and employers. H…
GoodRx Holdings, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
GDRX-DEBT
Debt stack $541.4M
90%
Market cache reports total debt of $541.4M.
GDRX-DEBT-9743
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2018-12-31.
GoodRx Holdings, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for GoodRx Holdings, Inc..
GoodRx Holdings, Inc. Ownership
Holder
Name
Confidence
Evidence
GDRX-OWNER-FRANCISCO-PARTNERS-MANAGEMENT-LP
Francisco Partners Management, LP
90%
13F overlay lists Francisco Partners Management, LP as top holder; 179 tracked holders.
GoodRx Holdings, Inc. Extended Supply Chain Network